Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business |
Looking for Device Contract Manufacturing Organizations? | |
| Recommended Events BioEngineering Insights 2009 ------------------------------------- | 
Register Now |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| 
| July 9, 2009 |
| Thanks to Lead SoCalBio Sponsors |  |
| Apply Now to Make a Presentation at the SoCalBio Investor/Partnership Conference | Is your firm an innovative advanced medical technology or biotech company interested in raising capital, partnering your products or technologies, or initiating strategic alliances? If so, apply now for a company presentation slot during the 11th SoCalBio Investor and Partnership Conference on Sep. 17, 2009 at the Loews Hotel in Santa Monica. Send an executive summary |
SoCalBio Events in July | July 9, 5:00 - 9:00 pm (California Club in downtown LA) July 29, 4:00 - 7:00 pm (Ernst & Young's Office in downtown LA)  SoCalBio Networking Forum in Los Angeles : "Bioscience Business Models Beyond the Current Systemic Funding Drought"
|
SoCalBio-Recommended Seminars | Behind the Logo
Successful Brand Strategies:
An Interactive Seminar Series Offered by  This is a must-attend series of seminars on business branding strategies for innovators and entrepreneurs. These seminars are delivered by Sasha Strauss (photo right), an award-winning speaker and graduate professor of brand strategy at USC who regularly guest lectures at top business schools such as MIT, Cornell, Columbia, UCLA Anderson and USC Marshall. Brand development strategy and methodology will be presented from previous work delivered for the world's most powerful brands, from Adobe and Microsoft to Johnson & Johnson and eBay... For dates and to RSVP, click here |
NIH |  Obama Picks Geneticist Francis Collins to Lead the NIH
Dr. Collins's (photo right) selection, which had been rumored for weeks, was praised by top scientists and research advocacy organizations for whom the health institute is a crucial patron... Read more |
From the Lab Bench | UCLA Research Indicates That Embryonic Stem Cells and Reprogrammed Skin Cells Have Inherent Differences The data from the study suggest that embryonic stem cells and the reprogrammed cells, known as induced pluripotent stem
(iPS) cells, have overlapping but still distinct gene expression signatures. The differing signatures were evident regardless of where the cell lines were generated, the methods by which they were derived or the species from which they were isolated, said William Lowry, a researcher with the Broad stem cell ... Read more UCSB Alzheimer's Research Yields Potential Drug Target Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may lead to new drugs for the disease.... Read more |
New Products | Convergent Informatics of Moorpark Calif. Introduces eCompany In A Box Convergent Informatics, Inc. -- a SoCalBio member -- has launched a new product, eCompany in a Box. The product supports entrepreneurs, start-ups, and small companies who need integrated voice communication, email and calendar, a simple web presence, document sharing, and backups. eCompany in a Box is now available in limited release. For more information, contact Noel O'Connor at 888-753-7311, or email
sales@ecompany-in-a-box.com or submit a purchase request at http://www.ecompany-in-a-box.com/purchase |
Clinical Data | Amgen Shares Leap on Late-Stage Denosumab Data Amgen shares got a big boost after the company posted new late-stage data on denosumab demonstrating that its bone drug -- denosumab -- outperformed a competing therapy -- Zometa -- from Novartis ... Read more Aeolus Pharmaceuticals' AEOL 10150 Significantly Increases Survival in Mice Exposed to Radiation when Administered After Exposure The six month study, led by Zeljko
Vujaskovic, M.D. Ph.D. of Duke University Medical Center, was designed to test the efficacy of the Mission Viejo-based AEOL 10150 as a treatment for damage to the lungs due to exposure to radiation... Read more FDA Seeks More Data on Spectrum's Blood Cancer Drug Spectrum Pharmaceuticals of Irvine said it plans to respond to the Food and Drug Administration request, but final approval of its drug Zevalin probably will be delayed by two months... Read more |
FDA Approvals | FDA Clears Osmetech's Cystic Fibrosis Test The eSensor Cystic Fibrosis Genotyping Test bty the Pasadena-based Osmetech screens for cystic fibrosis gene carriers in adults of reproductive age, and functions as an aid in newborn screening and as a confirmatory diagnostic test for the disease in newborns and children... Read more
Watson Gets FDA Nod for Two Generic Nicotine Gums
The FDA approval covers nicotine gum in strengths of 2 mg and 4 mg, in fruit and cinnamon flavors. The Corona-based Watson said it will start shipping the product immediately. The gum is sold by GlaxoSmithKline PLC as Nicorette Fruit Chill and Cinnamon Surge gums.... Read more
|
About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
 Editor: Ahmed A. EnanySouthern California Biomedical Council (SoCalBio) |
|
|
